Tuesday, July 20, 2021

US FDA News: Statins: Drug Safety Communication - FDA Requests Removal of Strongest Warning Against Using Cholesterol-lowering Statins During Pregnancy

FDA is requesting removal of its strongest warning against using cholesterol-lowering statin medicines in pregnant patients.
Read more: Statins: Drug Safety Communication - FDA Requests Removal of Strongest Warning Against Using Cholesterol-lowering Statins During Pregnancy